Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating expenses:
Research and development expenses	$ 8,004,852	$ 3,761,646	$ 13,848,538	$ 8,922,961
General and administrative expenses	4,691,321	3,331,006	8,270,049	6,648,913
Total operating expenses	12,696,173	7,092,652	22,118,587	15,571,874
Loss from operations	(12,696,173)	(7,092,652)	(22,118,587)	(15,571,874)
Interest income (expenses), net
Interest income	750,654	74,547	1,479,995	80,247
Interest expense	(995,397)	0	(1,962,242)	0
Interest income (expenses), net	(244,743)	74,547	(482,247)	80,247
Loss before income taxes	(12,940,916)	(7,018,105)	(22,600,834)	(15,491,627)
Benefit for income taxes	1,406,021	1,198,905	1,406,021	1,198,905
Net loss	(11,534,895)	(5,819,200)	(21,194,813)	(14,292,722)
Comprehensive loss	$ (11,534,895)	$ (5,819,200)	$ (21,194,813)	$ (14,292,722)
Per share information:
Net loss per share, basic (in dollars per share)	$ (0.37)	$ (0.2)	$ (0.69)	$ (0.5)
Net loss per share, diluted (in dollars per share)	$ (0.37)	$ (0.2)	$ (0.69)	$ (0.5)
Weighted average common shares outstanding, basic (in shares)	30,802,498	28,451,579	30,616,310	28,450,104
Weighted average common shares outstanding, diluted (in shares)	30,802,498	28,451,579	30,616,310	28,450,104